DAWN (Day One Biopharmaceuticals, Inc.) Stock Market Reviews

crown

search

Read and share opinions on DAWN (Day One Biopharmaceuticals, Inc.) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the stoc

DAWN

Day One Biopharmaceuticals, Inc.

clarify Biotechnology

bookmark Healthcare

public United States

Sell Neutral Buy

Latest News

Day One Biopharmaceuticals (DAWN): Examining Valuation Following Recent Share Price Rebound
Nov 14, 2025
Day One Biopharmaceuticals to Acquire Mersana Therapeutics in Deal Worth Up to $285 Million
Nov 13, 2025
Day One Announces New OJEMDA™ (tovorafenib) Data to be Presented in Oral Session at the 2025 Society for Neuro-Oncology (SNO) Annual Meeting
Nov 10, 2025
Day One Biopharmaceuticals (DAWN): Revenue Forecast to Grow 30.6% Annually, Reinforcing Bull Case
Nov 6, 2025
Day One Biopharmaceuticals Inc (DAWN) Q3 2025 Earnings Call Highlights: Strong Revenue Growth ...
Nov 5, 2025
Day One Biopharmaceuticals, Inc. (DAWN) Reports Q3 Loss, Tops Revenue Estimates
Nov 4, 2025
Wall Street Analysts See a 234.66% Upside in Day One Biopharmaceuticals (DAWN): Can the Stock Really Move This High?
Oct 30, 2025
Day One to Report Third Quarter 2025 Financial Results Tuesday, November 4, 2025
Oct 21, 2025
Wall Street Analysts Think Day One Biopharmaceuticals (DAWN) Could Surge 241.59%: Read This Before Placing a Bet
Oct 14, 2025
Day One Biopharmaceuticals (DAWN) Moves 7.0% Higher: Will This Strength Last?
Oct 6, 2025

Reviews